The Application of Cold Energy Units in the Pharmaceutical Industry.

The scale of China's pharmaceutical cold chain logistics market is gradually expanding, and industry concentration is expected to gradually increase.

Pharmaceutical cold chain logistics, also known as pharmaceutical cold chain, belongs to a segmented field of the logistics industry. It mainly refers to a systematic engineering of refrigerated drug entities from producers to users, including a series of links such as production, transportation, storage, and use, in order to meet the needs of human disease diagnosis and treatment. At each link, the refrigeration effect must be ensured. Due to the direct impact of temperature deviation on the quality of cold chain drugs, compared to other logistics systems, the requirements of pharmaceutical cold chain logistics are more stringent, with characteristics such as complexity, high cost, timeliness, and high coordination.

With the gradual progress of science and technology in our country, the types of medicine are gradually enriched, and the number of refrigerated drugs is gradually increasing. Common refrigerated drugs mainly include IVD, vaccines, blood products, medical devices (excluding IVD), and biological products. Among them, biological products account for the largest proportion in the overall market, reaching 40.15%; Next is IVD, with a market share of 23.57%; The third ranked product is blood products, with a market share of 12.42%; In addition, vaccines have become the fastest-growing category, with a rapid increase in market share to 11.58%.

In recent years, China's social and economic development has been rapid, and consumers' attention to their own health has gradually increased. Per capita healthcare expenses have gradually increased, and the demand for medicine has continued to grow, indirectly driving the rapid development of the pharmaceutical logistics market. With the continuous deepening of the reform of China's pharmaceutical distribution system, supporting facilities such as pharmaceutical logistics centers, warehouses, and transportation vehicles are gradually improving, promoting the stable growth of the pharmaceutical logistics market scale. According to data released by the China Union of Things Pharmaceutical Logistics Branch, in 2022, the total amount of pharmaceutical logistics in China reached 298.83 billion yuan, an increase of 6.91% compared to the previous year. As a sub industry of pharmaceutical logistics, the pharmaceutical cold chain logistics market is gradually growing.

According to the "Feasibility Study Report on the Chinese Medical Cold Chain Logistics Market from 2023 to 2027" released by the Xinsijie Industry Research Center, as the types of refrigerated drugs in China gradually increase, the demand for drug transportation and distribution gradually increases, providing a stable foundation for the rapid development of the pharmaceutical cold chain logistics market. Due to the outbreak of the epidemic, the rapid growth of COVID-19 vaccine production and the increasing transportation demand for biological products have promoted the gradual expansion of China's pharmaceutical cold chain logistics market. In 2022, the scale of China's pharmaceutical cold chain logistics market reached 162.12 billion yuan.

So according to the needs of the industry, we are also actively developing products and launching constant frequency Condensing Units, which have strong stability and energy utilization efficiency. We have adopted a relatively efficient energy utilization rate and have advanced control systems.